Lucid Diagnostics Retained Earnings (Accumulated Deficit) 2021-2024 | LUCD
Lucid Diagnostics retained earnings (accumulated deficit) from 2021 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Lucid Diagnostics Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-204 |
| 2023 | $-151 |
| 2022 | $-98 |
| 2021 | $-42 |
| 2020 | $-14 |
| Lucid Diagnostics Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-204 |
| 2024-09-30 | $-192 |
| 2024-06-30 | $-180 |
| 2024-03-31 | $-169 |
| 2023-12-31 | $-151 |
| 2023-09-30 | $-140 |
| 2023-06-30 | $-126 |
| 2023-03-31 | $-114 |
| 2022-12-31 | $-98 |
| 2022-09-30 | $-83 |
| 2022-06-30 | $-69 |
| 2022-03-31 | $-54 |
| 2021-12-31 | $-42 |
| 2021-09-30 | $-31 |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.136B | $0.004B |
| Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. Lucid Diagnostics Inc. is based in NEW YORK. | |||